Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Lawrence, K. S."'
Autor:
Takao, Hoshino, Shinichiro, Uchiyama, Lawrence K S, Wong, Kazuo, Kitagawa, Hugo, Charles, Julien, Labreuche, Philippa C, Lavallée, Gregory W, Albers, Louis R, Caplan, Geoffrey A, Donnan, José M, Ferro, Michael G, Hennerici, Carlos, Molina, Peter M, Rothwell, P Gabriel, Steg, Pierre-Jean, Touboul, Éric, Vicaut, Pierre, Amarenco, Somsak, Tiamkao
Publikováno v:
Neurology. 96(1)
ObjectiveTo determine long-term vascular outcomes of Asian patients who experienced TIA or minor ischemic stroke and to compare the outcomes of Asian patients with those of non-Asian patients, in the context of modern guideline-based prevention strat
Autor:
Yunyun Xiong, Li Zheng, Vincent Mok, Qianhua Zhao, Qihao Guo, Xiaoniu Liang, Zhen Hong, Lawrence K. S. Wong, Winnie Cw Chu, Jianfeng Luo, Shuguang Chu, Ding Ding
Publikováno v:
Journal of Alzheimer's disease : JAD. 61(4)
Background Unlike western countries, data on white matter hyperintensity (WMH) in community dwelling elderly in Asian population is very limited. Objective To examine the relation between baseline WMH burden and the risk of incident cognitive decline
Autor:
David Školoudík, Natan M. Bornstein, Louis R. Caplan, Sabrina Anticoli, Philippa C. Lavallée, Geoffrey A. Donnan, Jong Moo Park, Shinichiro Uchiyama, Eric Vicaut, Gregory W. Albers, Julien Labreuche, Manuel Correia, Peter M. Rothwell, Linsay Monteiro Tavares, Heinrich J. Audebert, Wolfgang Heide, M.G. Hennerici, Michal Král, Lawrence K S Wong, Hsiu-Fen Lin, Peter J Kelly, José M. Ferro, Tomás Segura, Halim Abboud, Pierre-Jean Touboul, Fernando Góngora-Rivera, Francisco Purroy, P. Gabriel Steg, Yongjun Wang, TIAregistry.org Investigators, Carlos A. Molina, Pierre Amarenco
Publikováno v:
New England Journal of Medicine
Recercat. Dipósit de la Recerca de Catalunya
instname
Repositorio Abierto de la UdL
Universitad de Lleida
Recercat. Dipósit de la Recerca de Catalunya
instname
Repositorio Abierto de la UdL
Universitad de Lleida
Background After a transient ischemic attack (TIA) or minor stroke, the long-term risk of stroke and other vascular events is not well known. In this follow-up to a report on 1-year outcomes from a registry of TIA clinics in 21 countries that enrolle
Autor:
Bum Joon Kim, Eun-Jae Lee, Sun U Kwon, Jong-Ho Park, Yong-Jae Kim, Keun-Sik Hong, Lawrence K S Wong, Sungwook Yu, Yang-Ha Hwang, Ji Sung Lee, Juneyoung Lee, Joung-Ho Rha, Sung Hyuk Heo, Sung Hwan Ahn, Woo-Keun Seo, Jong-Moo Park, Ju-Hun Lee, Jee-Hyun Kwon, Sung-Il Sohn, Jin-Man Jung, Jose C Navarro, Dong-Wha Kang, Yong-Seok Lee, Kyung Ho Yu, Seong Hwan Ahn, Jae-Kwan Cha, Man-Seok Park, Jong S Kim, Byung-Woo Yoon, Byung-Chul Lee, Cheong-Mo Nam, Ja-Seong Koo, Hyo-Seok Nam, Kwang-Yeol Park, Dae-Hyun Kim, Hyun-Wook Nah, Yong-Jin Cho, Dong-Eog Kim, Moon-Ku Han, Kyung-Bok Lee, Seong Hyuk Heo, Ji Hoe Heo, Kyung-Hee Cho, Han-Young Kim, Young-Dae Kim, Ah-Hyun Cho, Kyeong-Yul Lee, Jin-Soo Lee, Eung-Gyu Kim, Im-Seok Koh, Nak-Cheon Choi, June Lee, Hee-Jeong Song, Byung-Soo Shin, June-Tae Kim, Soo-Joo Lee, Pil-Wook Chung, Seong-Heon Kim, June-Hong Lee, Dong-Ik Shin, Jin Kuk Do, Sang-Bong Lee, Young-Bae Lee, Bong-Goo Yoo, Sang Min Sung, Jeong-Wook Park, Tae-Kyung Lee, Maria Cristina Z San Jos, Artemio Roxas, Raquel J Mallarl-Alvarez, Ma. Epifania V Collantes, Lawrence K.S WONG, Wing-Chi Fong, Tak Hong Tsoi, Ping Wing Ng
Publikováno v:
ResearcherID
Summary Background The optimal treatment for patients with ischaemic stroke with a high risk of cerebral haemorrhage is unclear. We assessed the efficacy and safety of cilostazol versus aspirin, with and without probucol, in these patients. Methods I
Autor:
Jonas Yeung, Wai Sang Poon, X. L. Zhu, Danny T.M. Chan, Vincent Mok, Anne Y. Y. Chan, Lawrence K. S. Wong, Claire Ky. Lau, Michael C M Leung, Carol Yeung, Venus Tang, Rosanna Wong
Publikováno v:
World Neurosurgery. 82:987-993
Background Deep brain stimulation (DBS) is an effective but costly treatment for patients with advanced Parkinson disease (PD). This study examined the cost-effectiveness of DBS in relation to its improved effectiveness to help funding decision maker
Autor:
Edward H C, Wong, Simon C H, Yu, Alexander Y L, Lau, Venus S W, Hui, Cecilia S F, Leung, Joyce W Y, Hui, Deyond Y W, Siu, Jill M, Abrigo, K T, Lee, Colin A, Graham, Lawrence K S, Wong, Thomas W H, Leung
Publikováno v:
Hong Kong medical journal = Xianggang yi xue za zhi. 19(2)
To assess the outcome of acute ischaemic stroke patients who received intra-arterial therapy in our unit.Case series.A tertiary hospital in Hong Kong.Patients with ischaemic stroke due to large artery occlusion treated within 6 hours from symptom ons
Autor:
Jose C, Navarro, Christopher Li Hsian, Chen, Pedro Danilo J, Lagamayo, Melodia B, Geslani, Gaik Bee, Eow, Niphon, Poungvarin, Asita, de Silva, Lawrence K S, Wong, N, Venketasubramanian, G B, Eow
Publikováno v:
International journal of stroke : official journal of the International Stroke Society. 8(6)
Rationale The clinical effects of neuroprotective and/or neurorestorative therapies may vary according to location and size of the ischemic injury. Imaging techniques can be useful in stratifying patients for trials that may be beneficial against par
Autor:
Edward H C, Wong, Alexander Y L, Lau, Yannie O Y, Soo, Deyond Y W, Siu, Venus S W, Hui, Colin A, Graham, Thomas W H, Leung, Lawrence K S, Wong
Publikováno v:
Hong Kong medical journal = Xianggang yi xue za zhi. 18(2)
To investigate the safety and efficacy of stroke thrombolysis in a local hospital.Historical cohort study.A tertiary hospital in Hong Kong.The outcome of acute ischaemic stroke patients treated with intravenous tissue plasminogen activator between Oc
Publikováno v:
Hong Kong medical journal = Xianggang yi xue za zhi. 15(4)
Autor:
Thomas W, Leung, Wynnie W M, Lam, Simon C H, Yu, Cecilia S F, Leung, Yannie O Y, Soo, Lawrence K S, Wong
Publikováno v:
Hong Kong medical journal = Xianggang yi xue za zhi. 14(3)
Currently, when stroke patients are offered thrombolytic therapy, their ischaemic stroke subtypes are usually unknown. Given the risk of haemorrhage that accompanies thrombolytic therapy, unselective (or undiscriminating) use of recombinant tissue pl